CLIN.L - Clinigen Group Plc

LSE - LSE Delayed Price. Currency in GBp
Currency in GBp

Valuation Measures

Market Cap (intraday) 51.19B
Enterprise Value 31.34B
Trailing P/E 45.15
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.82
Price/Book (mrq)261.88
Enterprise Value/Revenue 33.18
Enterprise Value/EBITDA 616.27

Trading Information

Stock Price History

Beta (3Y Monthly) 0.52
52-Week Change 3-9.01%
S&P500 52-Week Change 32.33%
52 Week High 31,069.00
52 Week Low 3716.00
50-Day Moving Average 3964.40
200-Day Moving Average 3960.37

Share Statistics

Avg Vol (3 month) 3207.26k
Avg Vol (10 day) 3200.17k
Shares Outstanding 5132.48M
Float 122.35M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.06
Forward Annual Dividend Yield 40.64%
Trailing Annual Dividend Rate 30.06
Trailing Annual Dividend Yield 30.01%
5 Year Average Dividend Yield 40.55
Payout Ratio 428.00%
Dividend Date 3N/A
Ex-Dividend Date 4Mar 21, 2019
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Jun 30, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 5.99%
Operating Margin (ttm)12.27%

Management Effectiveness

Return on Assets (ttm)4.19%
Return on Equity (ttm)6.52%

Income Statement

Revenue (ttm)422.3M
Revenue Per Share (ttm)3.38
Quarterly Revenue Growth (yoy)24.50%
Gross Profit (ttm)140.1M
EBITDA 82.5M
Net Income Avi to Common (ttm)25.3M
Diluted EPS (ttm)19.90
Quarterly Earnings Growth (yoy)-17.50%

Balance Sheet

Total Cash (mrq)55.1M
Total Cash Per Share (mrq)0.43
Total Debt (mrq)247.5M
Total Debt/Equity (mrq)56.71
Current Ratio (mrq)1.54
Book Value Per Share (mrq)3.43

Cash Flow Statement

Operating Cash Flow (ttm)46.7M
Levered Free Cash Flow (ttm)29.24M